Prot #64041575RSV2003: A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adult Subjects Hospitaliz

Project: Research project

Project Details

StatusFinished
Effective start/end date4/23/174/23/20

Funding

  • Janssen Research & Development, LLC (Prot #64041575RSV2003)